N6-(3-Methyl-2-butenyl)adenosine; Isopentenyladenosine; N6-(2-Isopentenyl)adenosine; Isopentenyladenosine riboside; Riboprina; Riboprinum; 6-(gamma,gamma-Dimethylallylamino)purine riboside; 2-IPA; ADENOSINE, N-(3-METHYL-2-BUTENYL)-; 6-(3-Methyl-2-butenylamino)purine riboside; UNII-8EU82FAZ5J; Dimethylallyladenosine; N-(3-methylbut-2-en-1-yl)adenosine; N-Isopentenyladenosine; Isopentenyl adenosine; Isopentenyl adenine riboside; N(6)-(Delta(2)-isopentenyl)adenosine; 8EU82FAZ5J; N-(3-Methyl-2-butenyl)adenosine; N(6)-(2-isopentenyl)adenosine; N-(3-methylbut-2-enyl)adenosine; N(6)-(3-methyl-2-butenyl)adenosine; SQ 22558; ZK 20 242; Riboprine [USAN:INN]; Riboprinum [INN-Latin]; Riboprina [INN-Spanish]; N(sup 6)-Isopentenyladenosine; N(sup 6)-Dimethylallyladenosine; EINECS 231-771-3; N(sup 6)-(2-Isopentenyl)adenosine; NSC 105546; Riboprin; MFCD00005741; 2iP Riboside; N(sup 6)-(delta(sup 2)-Isopentenyl)adenosine; NSC-105546; 6-N-((3-Methyl-2-butenyl)amino)-9beta-D-ribofuranosylpurine; 9beta-D-Ribofuranosyl-9H-purine, N-(3-methyl-2-butenylamino)-; Riboprine (USAN/INN); N6-Dimethylallyladenosine; 6-N-((3-Methyl-2-butenyl)amino)-9-beta-D-ribofuranosyl-9H-purine; 6-(3,3-Dimethylallylamino)-9-(b-D-ribofuranosyl)purine; SCHEMBL4599; DSSTox_CID_31617; DSSTox_RID_97501; DSSTox_GSID_57828; 6-N-((3-Methyl-2-butenyl)amino)-9.beta.-D-ribofuranosylpurine; CHEMBL452867; 6-N-((3-Methyl-2-butenyl)amino)-9-.beta.-D-ribofuranosyl-9H-purine; DTXSID1057828; ZINC57125; EBD80372; N-6-(delta-2-Isopentenyl)adenosine; Tox21_113776; 2058AC; AKOS016009606; CS-W011925; DB11933; DS-5147; SB19217; NCGC00253650-01; N6-(.DELTA.2-Isopentenyl)adenine riboside; N6-(.gamma.,.gamma.-Dimethylallyl)adenosine; C16427; D05726; 724G767; Q973089; SR-01000883994; SR-01000883994-1